HomeA2LC34 • BVMF
Alcon Inc
R$49.89
Nov 22, 8:00:00 PM GMT-3 · BRL · BVMF · Disclaimer
BR listed securityCH headquartered
Previous close
R$49.89
Year range
R$35.88 - R$56.76
Market cap
38.32B CHF
Avg Volume
374.00
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
2.45B5.37%
Operating expense
1.04B-1.42%
Net income
263.00M28.92%
Net profit margin
10.7222.37%
Earnings per share
0.8122.73%
EBITDA
620.00M19.23%
Effective tax rate
9.93%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
1.99B88.78%
Total assets
30.36B3.38%
Total liabilities
8.97B-2.65%
Total equity
21.39B
Shares outstanding
494.60M
Price to book
1.15
Return on assets
2.76%
Return on capital
3.16%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
263.00M28.92%
Cash from operations
747.00M41.75%
Cash from investing
-483.00M-217.76%
Cash from financing
-81.00M-910.00%
Net change in cash
194.00M-50.26%
Free cash flow
661.88M69.93%
About
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Founded
1945
Website
Employees
25,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu